Prelude Therapeutics Inc Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Prelude Therapeutics Inc quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Prelude Therapeutics Inc Assets for the quarter ending September 30, 2024 was $197M, a 23.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$197M	-$61.3M	-23.7%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$224M	-$56.3M	-20.1%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$247M	+$48.8M	+24.6%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$278M	+$57.2M	+25.9%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$259M	+$16.2M	+6.68%	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$281M	+$21.6M	+8.32%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$198M	-$82.4M	-29.3%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$221M	-$84.6M	-27.7%	Dec 31, 2022	10-K	2024-02-15
Q3 2022	$242M	-$88.9M	-26.8%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$259M	-$90.5M	-25.9%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$281M	-$89.2M	-24.1%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$305M	+$81.5M	+36.5%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$331M	+$91.5M	+38.2%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$350M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$370M			Mar 31, 2021	10-Q	2021-05-11
Q4 2020	$224M	+$202M	+922%	Dec 31, 2020	10-K	2022-03-17
Q3 2020	$240M			Sep 30, 2020	10-Q	2020-11-10
Q4 2019	$21.9M			Dec 31, 2019	10-K	2021-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.